Τμήμα Μηχανικών Επιστήμης Υλικών Πανεπιστήμιο Ιωαννίνων Πολυτεχνική Σχολή
 
 
foto-header
Είστε εδώ: Αρχική σελίδα > Ανακοινώσεις > Ανακοίνωση #5142

«Multi-action Anticancer Metallodrugs» (διάλεξη), Αμφιθέατρο "Ιωάννης Τσαγκάρης", Τμ. Χημείας, Πέ. 23/4/26, 12.00-13.00

23 Απρ. 2026


Την Πέμπτη 23 Απριλίου στις 12.00-13.00

η συνεργάτης του Εργαστηρίου Βιολογικής Ανόργανης Χημείας του Τμήματος Χημείας

Prof. Dr Andrea Erxleben, (https://research.universityofgalway.ie/en/persons/andrea-erxleben/)

School of Biological and Chemical Sciences, Cellular & Molecular Medicine

Institute for Health Discovery and Innovation

National University of Ireland (NUI), Galway



θα δώσει διάλεξη στο Αμφιθέατρο του Τμήματος Χημείας "Ιωάννης Τσαγκάρης" (Αμφ 2)

με τίτλο



« Multi-action Anticancer Metallodrugs »




Βιογραφικό Ομιλήτριας:


Short CV Dr Andrea Erxleben

Biography

since 2017: Senior Lecturer, National University of Ireland (NUI), Galway, Ireland

since 2007: Lecturer in Inorganic Chemistry, NUI Galway

2004: Visiting Professor, Institute of Inorganic Chemistry of the University of Vienna, Austria 2002 - 2006: Privatdozent, University of Dortmund, Germany

2002: Habilitation, University of Dortmund, Germany

1995 - 1997: Postdoctoral fellow, McGill University, Montréal

1995: Dr. rer. nat. (PhD), University of Dortmund, Germany

1992: Dipl.-Chem, University of Dortmund, Germany



Research Interests

Her research interests comprise Medicinal Inorganic Chemistry and Pharmaceutical Solid State Chemistry. Research activities in the area of Medicinal Inorganic Chemistry are centered on the synthesis and study of anticancer metallodrugs. A specific focus is on the development of new Pt(IV) anticancer pro-drugs with reduced side effects, metal complexes with receptor-specific carriers for target-delivery and selective accumulation into cancer tissue and on metal complexes that exhibit anticancer activity by irreversibly cleaving the tumour cell DNA. My research activities in the field of solid state chemistry of pharmaceuticals are aimed at improving the bioavailability and thus the therapeutic efficacy of poorly soluble drugs, including antibiotics, via co-amorphisation, co-crystallisation, control of crystal size and habit and polymorph control.


Καταχωρήθηκε από:  Ακης Αγαθόπουλος

Επιστροφή